149 related articles for article (PubMed ID: 22473661)
1. Organogold(III) supramolecular polymers for anticancer treatment.
Zhang JJ; Lu W; Sun RW; Che CM
Angew Chem Int Ed Engl; 2012 May; 51(20):4882-6. PubMed ID: 22473661
[TBL] [Abstract][Full Text] [Related]
2. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
3. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.
Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of cytotoxicity of selected organogold(III) compounds.
Coronnello M; Mini E; Caciagli B; Cinellu MA; Bindoli A; Gabbiani C; Messori L
J Med Chem; 2005 Oct; 48(21):6761-5. PubMed ID: 16220992
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
[TBL] [Abstract][Full Text] [Related]
6. A cytotoxic and cytostatic gold(III) corrole.
Teo RD; Gray HB; Lim P; Termini J; Domeshek E; Gross Z
Chem Commun (Camb); 2014 Nov; 50(89):13789-92. PubMed ID: 25252099
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
[TBL] [Abstract][Full Text] [Related]
9. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effect and mechanism of a Se-modified porphyrin Au(III) complex.
Yang FR; Li Y; Zhang XH; Wang M; Guo HR; Ruan WJ
Bioorg Med Chem Lett; 2015 Sep; 25(17):3592-6. PubMed ID: 26152428
[TBL] [Abstract][Full Text] [Related]
11. Atypical fluoroquinolone gold(III) chelates as potential anticancer agents: relevance of DNA and protein interactions for their mechanism of action.
Gouvea LR; Garcia LS; Lachter DR; Nunes PR; de Castro Pereira F; Silveira-Lacerda EP; Louro SR; Barbeira PJ; Teixeira LR
Eur J Med Chem; 2012 Sep; 55():67-73. PubMed ID: 22835721
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.
Serratrice M; Cinellu MA; Maiore L; Pilo M; Zucca A; Gabbiani C; Guerri A; Landini I; Nobili S; Mini E; Messori L
Inorg Chem; 2012 Mar; 51(5):3161-71. PubMed ID: 22339487
[TBL] [Abstract][Full Text] [Related]
13. Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy.
Kouodom MN; Boscutti G; Celegato M; Crisma M; Sitran S; Aldinucci D; Formaggio F; Ronconi L; Fregona D
J Inorg Biochem; 2012 Dec; 117():248-60. PubMed ID: 22877925
[TBL] [Abstract][Full Text] [Related]
14. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
Ronconi L; Marzano C; Zanello P; Corsini M; Miolo G; Maccà C; Trevisan A; Fregona D
J Med Chem; 2006 Mar; 49(5):1648-57. PubMed ID: 16509581
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Gold(I) Complexes Containing Cinnamide: In Vitro Evaluation of Anticancer Activity in 2D and 3D Spheroidal Models of Melanoma and In Vivo Angiogenesis.
Ganga Reddy V; Srinivasa Reddy T; Privér SH; Bai Y; Mishra S; Wlodkowic D; Mirzadeh N; Bhargava S
Inorg Chem; 2019 May; 58(9):5988-5999. PubMed ID: 30985125
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinases as potential anti-cancer targets for gold(III) complexes.
Zhang JJ; Ng KM; Lok CN; Sun RW; Che CM
Chem Commun (Camb); 2013 Jun; 49(45):5153-5. PubMed ID: 23629480
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
[TBL] [Abstract][Full Text] [Related]
18. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles.
Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L
Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of polymeric gold glyco-conjugates as anti-cancer agents.
Ahmed M; Mamba S; Yang XH; Darkwa J; Kumar P; Narain R
Bioconjug Chem; 2013 Jun; 24(6):979-86. PubMed ID: 23631753
[TBL] [Abstract][Full Text] [Related]
20. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
